Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

12 filings reported holding ACST - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.27M shares of 15.5M outstanding shares and own 8.17% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (497K shares), BANK OF AMERICA CORP /DE/ (495K shares), ADAR1 Capital Management, LLC (217K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (36.7K shares), Royal Bank of Canada (12.6K shares), NATIONAL BANK OF CANADA /FI/ (2.9K shares), UBS Group AG (1.95K shares), MORGAN STANLEY (1.88K shares), Federation des caisses Desjardins du Quebec (28 shares), and NBC SECURITIES, INC. (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.